Cybin is trading 5.1% down at $12.98 after broader U.S. equity weakness following hotter-than-expected August producer-price inflation and rising Treasury yields.
- The S&P 500, Nasdaq Composite and Dow Jones are each down more than 0.5%, creating a risk-off backdrop.
- Cybin announced a September 16 Morgan Stanley healthcare-conference fireside chat; the release does not link the event to the decline.